HALO

Halozyme Therapeutics, Inc. News Headlines

$9.63
*  
0.17
1.73%
Get HALO Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA - Analyst Blog
9/19/2014 5:20:00 PM - Zacks.com

Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape
9/18/2014 9:39:00 AM - Zacks.com

Halozyme Therapeutics : SWOG To Resume Trial In Advanced Pancreatic Cancer Drug
9/18/2014 9:24:00 AM - RTT News

5 Stocks With Big Insider Buying
9/17/2014 12:28:00 PM - TheStreet

InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO
9/17/2014 11:01:00 AM - Seeking Alpha

Recent Price Decline Creates An Attractive Entry Point For Halozyme
9/16/2014 10:35:00 AM - Seeking Alpha

Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog
9/15/2014 1:50:00 PM - Zacks.com

Sector Update: Health Care Stocks Mixed; Baxter International, Halo Therapeutics Declining Despite Regulatory OKs for Hemophilia Drug
9/15/2014 1:22:13 PM - MT Newswires

Sector Update: Health Care
9/15/2014 1:19:18 PM - MT Newswires

Halozyme Is Worth Betting On
9/15/2014 12:02:00 PM - Seeking Alpha

FDA Okays Baxter's Hyqvia To Treat Adults With Primary Immunodeficiency
9/12/2014 8:18:00 PM - RTT News

Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock - Tale of the Tape
9/8/2014 8:42:00 AM - Zacks.com

Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog
9/5/2014 5:00:00 PM - Zacks.com

Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog
8/14/2014 10:53:00 AM - Zacks.com

Halozyme Therapeutics Q2 Loss Narrows, Results Beat View
8/11/2014 9:27:00 PM - RTT News

Halozyme Therapeutics Q2 Loss Narrows - Quick Facts
8/11/2014 5:13:00 PM - RTT News

Earnings Reaction History: Halozyme Therapeutics Inc., 33.3% Follow-Through Indicator, 15.0% Sensitive
8/11/2014 11:51:56 AM - MT Newswires

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha

U.S. Hot Stocks: Hot Stocks to Watch
7/11/2014 9:11:00 AM - Dow Jones Business News

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts - Part 2
6/25/2014 9:09:00 AM - Seeking Alpha

Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Analyst Blog
6/11/2014 12:16:00 PM - Zacks.com

Halozyme Study Clinical Hold Lifted by FDA - Analyst Blog
6/5/2014 6:26:00 PM - Zacks.com

Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results
6/5/2014 2:52:41 PM - Benzinga

Thursday's ETF Movers: XBI, EWD
6/5/2014 2:11:53 PM - BNK Invest